Involvement of Renin–Angiotensin System Inhibition, the Potential Risk of Danshen in the Treatment of Pregnancy‐Induced Hypertension

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1573|29|9|1421-1422

ISSN： 0951-418x

Source： PHYTOTHERAPY RESEARCH, Vol.29, Iss.9, 2015-09, pp. : 1421-1422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum Uric Acid and the Renin‐Angiotensin System in Hypertension

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 26, Iss. 6, 1978-06 ,pp. : 241-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combinations of inhibitors of the renin–angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine

By Mourad Jean-Jacques   Le Jeune Sylvain   Pirollo Anthony   Mourad Clarisse   Gaudouen Yann   Lopez-Sublet Marilucy  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2263-2276

Informa Healthcare

Access to resources Recommend Favorite

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension

By Engeli Stefan   Sharma Arya M.  

Journal of Molecular Medicine, Vol. 79, Iss. 1, 2001-03 ,pp. : 21-29

Springer Publishing Company

Access to resources Recommend Favorite

The preeclampsia enigma and the renin-angiotensin system

By Luft Friedrich  

Journal of Molecular Medicine, Vol. 78, Iss. 2, 2000-02 ,pp. : 63-65

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a Long-Term Pharmacological Interruption of the Renin-Angiotensin System on the Fibrinolytic System in Essential Hypertension

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 67-75

Karger

Access to resources Recommend Favorite